Literature DB >> 18067030

Smoking to self-medicate attentional and emotional dysfunctions.

Jean-G Gehricke1, Sandra E Loughlin, Carol K Whalen, Steven G Potkin, James H Fallon, Larry D Jamner, James D Belluzzi, Frances M Leslie.   

Abstract

Individuals with attentional and emotional dysfunctions are most at risk for smoking initiation and subsequent nicotine addiction. This article presents converging findings from human behavioral research, brain imaging, and basic neuroscience on smoking as self-medication for attentional and emotional dysfunctions. Nicotine and other tobacco constituents have significant effects on neural circuitry underlying the regulation of attention and affect. Age, sex, early environment, and exposure to other drugs have been identified as important factors that moderate both the effects of nicotine on brain circuitry and behavior and the risk for smoking initiation. Findings also suggest that the effects of smoking differ depending on whether smoking is used to regulate attention or affect. Individual differences in the reinforcement processes underlying tobacco use have implications for the development of tailored smoking cessation programs and prevention strategies that include early treatment of attentional and emotional dysfunctions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18067030     DOI: 10.1080/14622200701685039

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  64 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity.

Authors:  Alexandra S Potter; David J Bucci; Paul A Newhouse
Journal:  Psychopharmacology (Berl)       Date:  2011-10-04       Impact factor: 4.530

3.  Nicotine Addiction and Psychiatric Disorders.

Authors:  Munir Gunes Kutlu; Vinay Parikh; Thomas J Gould
Journal:  Int Rev Neurobiol       Date:  2015-09-19       Impact factor: 3.230

4.  Associations between tobacco and nicotine product use and depressive symptoms among college students in Texas.

Authors:  Frank C Bandiera; Alexandra Loukas; Anna V Wilkinson; Cheryl L Perry
Journal:  Addict Behav       Date:  2016-06-29       Impact factor: 3.913

5.  Interparental conflict and long-term adolescent substance use trajectories: The role of adolescent threat appraisals.

Authors:  Gregory M Fosco; Mark E Feinberg
Journal:  J Fam Psychol       Date:  2018-03

Review 6.  Unique, long-term effects of nicotine on adolescent brain.

Authors:  Frances M Leslie
Journal:  Pharmacol Biochem Behav       Date:  2020-07-30       Impact factor: 3.533

7.  Sex differences in acute relief of abstinence-induced withdrawal and negative affect due to nicotine content in cigarettes.

Authors:  Kenneth A Perkins; Joshua L Karelitz
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

8.  Nicotine patch vs. nicotine lozenge for smoking cessation: an effectiveness trial coordinated by the Community Clinical Oncology Program.

Authors:  Robert A Schnoll; Elisa Martinez; Kristina L Tatum; Marcella Glass; Albert Bernath; Daron Ferris; Patrick Reynolds
Journal:  Drug Alcohol Depend       Date:  2009-12-09       Impact factor: 4.492

9.  Relationship between cigarette smoking and childhood symptoms of inattention and hyperactivity/impulsivity in alcohol-dependent adults without attention-deficit hyperactivity disorder.

Authors:  Jaimee L Heffner; Candace S Johnson; Thomas J Blom; Robert M Anthenelli
Journal:  Nicotine Tob Res       Date:  2010-01-18       Impact factor: 4.244

10.  Situational fears: Association with negative affect-related smoking cognition among treatment seeking smokers.

Authors:  Jafar Bakhshaie; Andrew H Rogers; Brooke Y Kauffman; Melissa Fasteau; Julia D Buckner; Norman B Schmidt; Michael J Zvolensky
Journal:  Addict Behav       Date:  2018-06-09       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.